Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$512.33NASDAQ Closing Price as of 3:59PM ET 4/08/20

Today's Change+10.82(2.16%)
Bid (Size)$506.75 (1)
Ask (Size)$513.50 (5)
Day Low / High$488.00 - 514.11
Volume1.2 M
  • Latest Stories
  • Commentary and Analysis
Insider Trends: Regeneron Pharmaceuticals Insider Exercises Options Derivative Securities, Sells for Taxes and Self, Selling Trend Unaffected
4:05PM ET 4/08/2020 MT Newswires

On Apr 06, 2020, EVP Finance CFO, Robert E Landry, exercised options/derivative securities for 3,000 shares. A portion of these optioned shares (2,304...

--Analyst Actions: Benchmark Capital Initiates Regeneron Pharmaceuticals at Hold
8:34AM ET 4/08/2020 MT Newswires

Price: 506.00, Change: +4.49, Percent Change: +0.90 ...

Regeneron Grants Zai Lab Rights to Develop, Commercialize Lymphoma Drug in China, Hong Kong, Taiwan, Macau
6:43AM ET 4/08/2020 MT Newswires

Regeneron Pharmaceuticals (REGN), a US biotech firm, and Zai Lab (ZLAB), a Chinese commercial-stage biopharmaceutical company, said Wednesday that Zai Lab...

Regeneron Pharmaceuticals, Sanofi Restructure Agreement for Praluent
11:07AM ET 4/07/2020 MT Newswires

Regeneron Pharmaceuticals (REGN) said Tuesday that it has restructured its Praluent (alirocumab) agreement with partner Sanofi (SNY), which is expected to...

Analyst Actions: Wells Fargo Lifts Regeneron Pharmaceuticals' Price Target to $435 From $370, Keeps Equal-Weight Rating
11:53AM ET 4/06/2020 MT Newswires

Regeneron Pharmaceuticals (REGN) has an average analyst rating of buy, with an average price target of $459. Price: 491.36, Change: -1.96, Percent Change:...

Analysts' Scale Up Regeneron Pharmaceuticals' 2020, 2021 Earnings Estimates
8:35AM ET 4/04/2020 MT Newswires

The 2020 and 2021 full year forecasted earnings estimates for Regeneron Pharmaceuticals Inc's (NASDAQ:REGN, Recent Price: 493.32) have been increased. The...

Insider Trends: Insider at Regeneron Pharmaceuticals Exercises Options Derivative Securities, Sells for Taxes and Self, Selling Trend Unaffected
4:54PM ET 4/03/2020 MT Newswires

On Apr 01, 2020, EVP Finance CFO, Robert E Landry, exercised options/derivative securities for 9,000 shares. A portion of these optioned shares (6,964...

S&P 500 Declines Sixth Week in Seven as Airlines, Financials Weigh
4:37PM ET 4/03/2020 MT Newswires

The Standard & Poor's 500 Index continued to be plagued by the economic fallout of COVID-19 as dismal data on the labor market coupled with increasingly...

Insider Trends: Insider at Regeneron Pharmaceuticals Exercises Options Derivative Securities, Sells for Taxes and Self, Selling Trend Unaffected
4:11PM ET 4/03/2020 MT Newswires

On Apr 01, 2020, EVP General Counsel and Secret, Joseph J LaRosa, exercised options/derivative securities for 15,000 shares. A portion of these optioned...

Regeneron, Sanofi Study Shows Potential of Eczema Drug for Children
10:01AM ET 4/03/2020 MT Newswires

Regeneron Pharmaceuticals (REGN) and partner Sanofi (SNY) said Friday Dupixent combined with standard-of-care topical corticosteroids improved the...